Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

7.69

+0.29 (3.92%)

At close: Jun 26, 2026, 4:00 PM EDT

7.66

-0.03 (-0.39%)

After-hours: Jun 26, 2026, 7:49 PM EDT

Xeris Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	111.75	111.04	71.62	67.45	121.97	67.27
Short-Term Investments	-	-	-	5	-	35.16
Cash & Short-Term Investments	111.75	111.04	71.62	72.45	121.97	102.43
Cash Growth	91.22%	55.04%	-1.15%	-40.60%	19.07%	-23.44%
Accounts Receivable	56.3	51.05	40.42	39.2	30.83	17.46
Inventory	74.23	68.67	48.18	38.84	24.74	18.12
Other Current Assets	9.4	9.55	7.45	5.78	9.29	4.59
Total Current Assets	251.68	240.31	167.66	156.26	186.82	142.6
Net Property, Plant & Equipment	26.98	27.06	28.21	29.18	9.51	6.63
Other Intangible Assets	85.37	88.08	98.92	109.76	120.61	131.45
Goodwill	22.86	22.86	22.86	22.86	22.86	22.86
Other Long-Term Assets	5.12	5.22	5.41	4.54	4.73	0.83
Total Assets	392.01	383.53	323.06	322.6	344.52	304.36
Accounts Payable	11.47	3.08	2.29	11.57	4.61	8.92
Accrued Expenses	96.5	95.38	75.88	36.35	64.78	68.13
Current Portion of Long-Term Debt	-	-	15.1	-	-	-
Current Portion of Leases	6.27	6.23	6.08	3.5	1.58	-
Other Current Liabilities	4.35	4.89	1.09	20.28	2.66	1.99
Total Current Liabilities	118.59	109.57	100.44	95.19	73.62	79.04
Long-Term Debt	221.22	220.34	217.01	190.93	187.08	88.07
Long-Term Leases	31.06	31.53	33.26	34.76	9.4	-
Other Long-Term Liabilities	8.13	8.4	1.97	8.5	29.24	42.02
Total Long-Term Liabilities	260.41	260.26	252.23	234.19	225.71	130.09
Total Liabilities	379	369.84	352.68	329.38	299.34	209.13
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-in Capital	682.09	685	642.26	610.25	599.97	555.36
Accumulated Other Comprehensive Income	-0.02	-0.03	-0.03	-0.03	-0.02	-0.03
Retained Earnings	-669.07	-671.31	-671.86	-617.03	-554.77	-460.11
Shareholders' Equity	13.01	13.69	-29.62	-6.78	45.19	95.23
Total Liabilities & Equity	392.01	383.53	323.06	322.6	344.52	304.36
Total Debt	258.55	258.1	271.45	229.19	198.06	88.07
Net Cash (Debt)	-146.8	-147.06	-199.83	-156.74	-76.09	14.37
Net Cash Growth	-	-	-	-	-	-69.28%
Net Cash Per Share	-0.84	-0.85	-1.36	-1.14	-0.56	0.18
Book Value	13.01	13.69	-29.62	-6.78	45.19	95.23
Book Value Per Share	0.07	0.08	-0.20	-0.05	0.33	1.21
Tangible Book Value	-95.22	-97.25	-151.4	-139.41	-98.28	-59.08
Tangible Book Value Per Share	-0.55	-0.56	-1.03	-1.01	-0.72	-0.75

SEC Filings: 10-K · 10-Q